4th Quarter - Report — FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC (2024)

Firm

FRESENIUS KABI USA LLC

Client

FRESENIUS KABI USA LLC

Income

—

Expenses

$75,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Pharmaceutical supply chain and API procurement, Global drug shortages, Tax reform

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE	Congressman Tom Davis
STEVEN CHASE WALKER New	Congressman Jodey Arrington

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO)

Pharmacy PHA

PBM reform, IRA Medicare Direct Negotiation, FDA/PTO

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE	Congressman Tom Davis
STEVEN CHASE WALKER New	Congressman Jodey Arrington

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

IRA, Part D redesign, rebates, AMP CAP, inflationary penalties, mid-year formulary changes, patent reform, terminal disclaimers, ancillary product patents

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE	Congressman Tom Davis
STEVEN CHASE WALKER New	Congressman Jodey Arrington

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Taxation/Internal Revenue Code TAX

Tax incentives for American production of pharmaceutical product, opioid taxes

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	Congressman John Tierney Senator Tom Carper
SARAH CHRISTINE D'ORSIE	Congressman Tom Davis
STEVEN CHASE WALKER New	Congressman Jodey Arrington

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Health Issues HCR

Patent Reform, terminal disclaimers, ancillary product patents

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	—
SARAH CHRISTINE D'ORSIE	—
STEVEN CHASE WALKER	—

Contacted: SENATE; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES

Manufacturing MAN

Buy America legislation, potential manufacturing tariffs, tax reform on fill and finish pharmaceutical products

Lobbyist	Covered position, as disclosed
TIMOTHY CASEY	—
SARAH CHRISTINE D'ORSIE	—
STEVEN CHASE WALKER	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.